ClosedSuppliesEuropeanOnderhandeling zonder bekendmaking

Combined sequencing and array platform for (epi)genetic diagnostics Pathology department

academisch ziekenhuis Maastricht · Onderhandeling zonder bekendmaking · 1 lots · 263935
Type
Supplies
38432000
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The Academisch Ziekenhuis Maastricht (azM) intends to purchase an integrated sequencing and array platform for (epi)genetic diagnostics within the Pathology department. The procurement concerns the delivery of a high-quality, fully integrated system that combines both DNA sequencing (e.g., next-generation sequencing) and microarray technology, suitable for diagnostic applications such as tumors, hereditary disorders, and epigenetic markers. The platform must comply with Dutch and EU standards for medical devices, including ISO 13485, CE marking, and GDPR compliance for patient data. Additionally, there are requirements for software integration with existing laboratory information systems, user-friendliness, maintenance and support contracts, and training for technicians and pathologists. The procedure is a negotiation without prior publication, which allows for rapid decision-making and direct communication with selected suppliers.

Supplies · Onderhandeling zonder bekendmaking · European procedure

European
Contract type
Supplies
Onderhandeling zonder bekendmaking
Estimated value
Estimate not published
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Maastricht
CharacteristicsCPV 38SuppliesEU tendersequencing platformarray platformepigenetics

01What is being requested

The Academisch Ziekenhuis Maastricht (azM) intends to purchase an integrated sequencing and array platform for (epi)genetic diagnostics within the Pathology department. The procurement concerns the delivery of a high-quality, fully integrated system that combines both DNA sequencing (e.g., next-generation sequencing) and microarray technology, suitable for diagnostic applications such as tumors, hereditary disorders, and epigenetic markers. The platform must comply with Dutch and EU standards for medical devices, including ISO 13485, CE marking, and GDPR compliance for patient data. Additionally, there are requirements for software integration with existing laboratory information systems, user-friendliness, maintenance and support contracts, and training for technicians and pathologists. The procedure is a negotiation without prior publication, which allows for rapid decision-making and direct communication with selected suppliers.

For the benefit of the Pathology department, the azM will purchase a combined sequencing and array platform for (epi)genetic diagnostics.

38432000Supplies
1Lot 1

02Outcome

Awarded

Illumina Netherlands BV

03Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

04Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

05Bidders in this segment

#Likely bidderFitWins
1Bruker Nederland B.V.SME7513×
2Agilent Technologies Netherlands B.V.SME7410×
3Waters Chromatography B.V.SME7312×
4Illumina Netherlands BVSME70
5Thermo Fisher ScientificUnknown67
6Carl Zeiss B.V.SME6610×

06Legal themes that may be relevant here

07Frequently asked questions

What is the scope of the assignment?
The assignment involves the delivery of a combined sequencing and array platform for (epi)genetic diagnostics.

Automatically compiled from the official tender data and documents.

08Estimated value versus the market

p25
€ 300K
median
€ 515K
p75
€ 1,7 mln
deze opdracht

Gegunde waarden in CPV 38 · leveringen n=331